Pharma News, Research & Solutions CSR News

Biogen and Eisai Launch Multiple Initiatives to Help Patients With Alzheimer's Disease Access ADUHELM™

Press Release

Programs now available to support patients and families with their treatment journey

Collaborations with Veterans Health Administration, CVS Health and NAFC focused on health disparities in underserved communities

Value-based agreements in progress with Cigna and other payers

FedEx Provides Lifesaving Supplies to Sick Children in Canada

Article

The Hospital for Sick Children (SickKids) is Canada's most research-intensive hospital and the largest centre dedicated to improving children's health in the country. As part of the SickKids VS Limits Campaign, the hospital is working to overcome the limits on delivering seamless healthcare to every child, limits like geography, made all the more challenging by the pandemic.

Pushing the Limits of What's Possible: A New Frontier of HP Innovation

By Enrique Lores, President & CEO at HP
Blog

The belief that anything is possible has always driven me in my career. From the day I arrived at HP as an engineering intern, I learned that if you can imagine it, you can achieve it—as long as you put in the work. And looking back on the storied history of our company, I can point to many examples where people have turned moments of inspiration into groundbreaking innovation.

United and Abbott Partner to Make Return to U.S. "Worry Free" For International Travelers With Home-testing Kits

Summary: 

Newly issued guidance from the U.S. Centers for Disease Control and Prevention now accepts rapid, self-administered testing option that meet its criteria

Press Release

Newly issued guidance from the U.S. Centers for Disease Control and Prevention now accepts rapid, self-administered testing option that meet its criteria

Alkermes Announces 2021 Alkermes Inspiration Grants® Program to Support Innovative Programs Focused on People Affected by Addiction, Serious Mental Illness or Cancer

Competitive Grants Program Application Period to Begin on May 20, 2021
Press Release

DUBLIN, May 13, 2021 /3BL Media/ -- Alkermes plc (Nasdaq: ALKS) today announced that the company will begin accepting applications for its Alkermes Inspiration Grants® program beginning on May 20, 2021. Now in its fifth year, this competitive grants program will provide up to a total of $500,000 in grants to assist nonprofit organizations in their work to address the needs of people living with addiction, serious mental illness or cancer.

Medtronic Receives “World Changing Idea” Recognition

Fast Company awards seek out ingenuity, impact, and passion to solve world problems
Article

Unprecedented pandemic response. First-of-its-kind heart technology. And innovation in reducing certain heart surgery-related infections. All of these Medtronic healthcare innovations are among the 2021 World Changing Ideas recognized on May 4, 2021 by Fast Company.

XRHealth: Crossing Realities Into the Future of Telehealth

Blog

In times of uncertainty, society often turns to new and disruptive innovations to overcome its challenges. Nowhere is that timely statement more relevant than in remote health care.

One company that has been making great strides in this area is XRHealth, a premium virtual reality (VR) medical company, certified (ISO, FDA, and HIPAA compliant) to develop FDA/CE-registered medical applications.

Simple Device Helps Address Childhood Malnutrition Challenges Globally

Blog

Strong partnerships are key for building health equity to effectively address health disparities, expand access to resources and remove barriers that prevent people from living healthy lives. And, tackling the global issue of childhood malnutrition, which affects more than 1 in 5 children around the world, is no simple task. 

Alkermes to Showcase Data From Psychiatry Portfolio at Upcoming Scientific Conferences Throughout Mental Health Awareness Month

New Outcomes Research in Patients With Schizophrenia or Bipolar I Disorder to be Presented
Press Release

DUBLINMay 4, 2021 /3BL Media/ -- Alkermes plc (Nasdaq: ALKS) recently announced plans to present clinical data and outcomes research from its psychiatry portfolio at three scientific conferences during Mental Health Awareness Month in May. The meetings, all held virtually, include:

Alkermes Supports Mental Health Clinical Research

Multimedia with summary

Alongside the The STARR Coalition, we recognize the need to support mental health research. Scientific, evidence-based mental health research is essential. To learn more about our commitment to supporting mental health clinical research and how to take actionable steps, visit: https://bit.ly/3bSkreC 

Pages

Subscribe to Pharma News, Research & Solutions